PRESS RELEASE
Jul 23, 2026
MindWalk Showcases ReefIQ™ for AI Drug Discovery at AMD Advancing AI
Jul 22, 2026
MindWalk Holdings Corp. (HYFT) Q4 2026 Earnings Call Transcript
Jul 22, 2026
MindWalk Holdings Corp. (HYFT) Reports Q4 Loss, Misses Revenue Estimates
Jul 22, 2026
MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure
Jul 13, 2026
MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026
Jul 06, 2026
MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity
Jul 01, 2026
MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery
Jun 12, 2026
MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery
Jun 10, 2026
MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ™, a Biological Context Layer for AI Drug Discovery
Jun 02, 2026
MindWalk's Preclinical Dengue Data Support a HYFT® Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns